BioNTech’s Fall: From Pandemic Hero to Restructuring
Six years ago, an almost unknown German pharmaceutical firm developed the first approved mRNA COVID-19 vaccine and changed the course of a global pandemic. BioNTech, which had spent over a decade developing mRNA for cancer with little commercial interest, partnered with Pfizer to roll out its Comirnaty coronavirus vaccine in record time, propelling the company and its founders to global